Search BRITE hierarchies

Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
  M MUSCULO-SKELETAL SYSTEM
    M05 DRUGS FOR TREATMENT OF BONE DISEASES
      M05B DRUGS AFFECTING BONE STRUCTURE AND MINERALIZATION
        M05BX Other drugs affecting bone structure and mineralization
          M05BX04 Denosumab
            D03684  Denosumab (USAN) <JP/US>

USP drug classification [BR:br08302]
  Antineoplastics
    Antineoplastic Adjuncts/Mitigators
      Denosumab
        D03684  Denosumab (USAN)
  Metabolic Bone Disease Agents
    RANK Ligand Inhibitor
      Denosumab
        D03684  Denosumab (USAN)

Therapeutic category of drugs in Japan [BR:br08301]
  3  Agents affecting metabolism
    39  Other agents affecting metabolism
      399  Miscellaneous
        3999  Others
          D03684  Denosumab (USAN); Denosumab (genetical recombination) (JAN)

Drug groups [BR:br08330]
  Anti-inflammatory
    DG01985  Disease modifying anti-rheumatic drug (DMARD)
      D03684  Denosumab
  Musculo-skeletal system agent
    DG03232  Osteoporosis agent
      D03684  Denosumab

Drug classes [BR:br08332]
  Antirheumatic agent
    DG01985  Disease modifying anti-rheumatic drug (DMARD)
      D03684  Denosumab
  Musculo-skeletal system agent
    DG03232  Osteoporosis agent
      D03684  Denosumab

Target-based classification of drugs [BR:br08310]
  Cytokines and receptors
    Cytokines
      Tumor necrosis factors
        TNFSF11 (RANKL, CD254) [HSA:8600] [KO:K05473]
          D03684  Denosumab (USAN) <JP/US>

New drug approvals in the USA [br08319.html]
  D03684

New drug approvals in Europe [br08329.html]
  D03684

New drug approvals in Japan [br08318.html]
  D03684

New drug approvals in the USA, Europe and Japan [br08328.html]
  D03684